Takanori Matsui et al.’s observations suggest that PEDF could have anti-angiogenic, anti-inflammatory and anti-thrombogenic properties in cultured myeloma cells through the interaction with LR, but not PEDFR [17]. This evidence concerns the gene PNPLA2 and plasma cell myeloma.